Anna S Berghoff
Overview
Explore the profile of Anna S Berghoff including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
148
Citations
3896
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Steindl A, Zach C, Berchtold L, Grisold A, Gatterbauer B, Eckert F, et al.
Br J Cancer
. 2025 Mar;
PMID: 40025253
Background: Existing prognostic models for breast cancer (BC) brain metastases (BM) overlook neurological symptoms. Thus, we explored the incidence and prognostic relevance of neurological symptoms in a real-world cohort of...
2.
Mair M, Hartenbach S, Tomasich E, Maas S, Bosch S, Widhalm G, et al.
Eur J Nucl Med Mol Imaging
. 2025 Feb;
PMID: 39969538
Purpose: High-grade meningiomas have high recurrence rates and limited prognosis. Radioligand therapies are approved in extracranial malignancies, but their value in brain tumours including meningiomas is unclear, as data on...
3.
Englisch C, Nopp S, Moik F, Steiner D, Starzer A, Fritzer-Szekeres M, et al.
JACC CardioOncol
. 2025 Feb;
7(2):141-152.
PMID: 39967200
Background: The hemostatic system is tightly interconnected with cancer. Research has focused predominantly on thrombotic complications, but less is known about bleeding and bleeding risk prediction. Growth differentiation factor (GDF)-15...
4.
Mair M, Leibetseder A, Heller G, Tomasich E, Muller L, Busse I, et al.
J Neurol
. 2025 Feb;
272(3):210.
PMID: 39954095
Purpose: The prognosis of diffuse gliomas previously classified as "lower-grade" is heterogeneous and complicates clinical decisions. We aimed to investigate the molecular profile of clinical outliers to gain insight into...
5.
Sahm F, Bertero L, Brandner S, Capper D, Goldbrunner R, Jenkinson M, et al.
Neuro Oncol
. 2024 Nov;
PMID: 39577862
Meningiomas are the most common primary intracranial tumors of adults. For meningiomas that progress or recur despite surgical resection and radiotherapy, additional treatment options are limited due to lack of...
6.
Berger J, Preusser M, Berghoff A, Bergen E
Cancer Treat Rev
. 2024 Nov;
121:102646.
PMID: 39492370
Ascites formation is a common complication of cancer with a significant symptomatic burden for patients. Malignant ascites (MA) is defined by the presence of tumor cells within the ascitic fluid....
7.
Puhr H, Berchtold L, Zingerle L, Felfernig M, Weissenbacher L, Jomrich G, et al.
Wien Klin Wochenschr
. 2024 Oct;
PMID: 39422753
No abstract available.
8.
Messmer J, Thommek C, Piechutta M, Venkataramani V, Wehner R, Westphal D, et al.
Immunity
. 2024 Oct;
57(11):2688-2703.e11.
PMID: 39368486
To improve immunotherapy for brain tumors, it is important to determine the principal intracranial site of T cell recruitment from the bloodstream and their intracranial route to brain tumors. Using...
9.
Puhr H, Berchtold L, Zingerle L, Felfernig M, Weissenbacher L, Jomrich G, et al.
Wien Klin Wochenschr
. 2024 Sep;
PMID: 39235615
Introduction: The role of the family history in the development and prognosis of gastroesophageal cancer is a controversially discussed topic as appropriate data from western cohorts are lacking. This study...
10.
Englisch C, Moik F, Steiner D, Starzer A, Berghoff A, Preusser M, et al.
Blood
. 2024 Aug;
144(22):2349-2359.
PMID: 39190465
Hemostatic imbalances are frequent in patients with cancer. Although cancer-associated thrombotic complications have been well characterized, data on bleeding events in patients with cancer are sparse. Therefore, we aimed to...